4
Changes in Ownership
Definium Therapeutics, Inc. Filed Acc 0000950170-23-030242
Chief Financial Officer sold 11,635 shares at an average $3.20 ($37,194)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Greenway Schond L. Chief Financial Officer | 2023-06-27 | Sale | −7,694 | $3.19 | $24,544 | 251,972 | D |
| Greenway Schond L. Chief Financial Officer | 2023-06-27 | Sale | −3,941 | $3.21 | $12,651 | 248,031 | D |
| Open-market sales · 11,635 sh · avg $3.20 · $37,194 | |||||||
Loading xslF345X04/ownership.xml…